Kumar Kandadi Muralidharan

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 9

Top Topics

Mild Cognitive Impairment

Estrogen Receptor

Top Venues

Journal of pharmacokinetics and pharmacodynamics

CPT: pharmacometrics & systems pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Kumar Kandadi Muralidharan, Kenneth G Kowalski, Xiao Tong, Samantha Budd Haeberlein, Rajasimhan Rajagovindan, Ivan Nestorov
Characterization of exposure-Clinical Dementia Rating-Sum of Boxes relationship in subjects with early Alzheimer's disease from the aducanumab Phase 3 trials. Journal of pharmacokinetics and pharmacodynamics 50 (1) (2023)
Kumar Kandadi Muralidharan, Kenneth G Kowalski, Xiao Tong, Samantha Budd Haeberlein, Rajasimhan Rajagovindan, Ivan Nestorov
Characterization of exposure-Clinical Dementia Rating-Sum of Boxes relationship in subjects with early Alzheimer's disease from the aducanumab Phase 3 trials. Journal of pharmacokinetics and pharmacodynamics 50 (1) (2023)
Kumar Kandadi Muralidharan, Kenneth G Kowalski, Xiao Tong, Samantha Budd Haeberlein, Rajasimhan Rajagovindan, Ivan Nestorov
Characterization of exposure-Clinical Dementia Rating-Sum of Boxes relationship in subjects with early Alzheimer's disease from the aducanumab Phase 3 trials. Journal of pharmacokinetics and pharmacodynamics 50 (1) (2023)
Kumar Kandadi Muralidharan, Kenneth G Kowalski, Xiao Tong, Samantha Budd Haeberlein, Rajasimhan Rajagovindan, Ivan Nestorov
Characterization of exposure-Clinical Dementia Rating-Sum of Boxes relationship in subjects with early Alzheimer's disease from the aducanumab Phase 3 trials. Journal of pharmacokinetics and pharmacodynamics 50 (1) (2023)
Kumar Kandadi Muralidharan, Kenneth G Kowalski, Xiao Tong, Samantha Budd Haeberlein, Rajasimhan Rajagovindan, Ivan Nestorov
Characterization of exposure-Clinical Dementia Rating-Sum of Boxes relationship in subjects with early Alzheimer's disease from the aducanumab Phase 3 trials. Journal of pharmacokinetics and pharmacodynamics 50 (1) (2023)
Kumar Kandadi Muralidharan, Kenneth G Kowalski, Xiao Tong, Samantha Budd Haeberlein, Rajasimhan Rajagovindan, Ivan Nestorov
Characterization of exposure-Clinical Dementia Rating-Sum of Boxes relationship in subjects with early Alzheimer's disease from the aducanumab Phase 3 trials. Journal of pharmacokinetics and pharmacodynamics (2023)
Kumar Kandadi Muralidharan, Kenneth G Kowalski, Xiao Tong, Samantha Budd Haeberlein, Rajasimhan Rajagovindan, Ivan Nestorov
Characterization of exposure-Clinical Dementia Rating-Sum of Boxes relationship in subjects with early Alzheimer's disease from the aducanumab Phase 3 trials. Journal of pharmacokinetics and pharmacodynamics 50 (1) (2023)
Kumar Kandadi Muralidharan, Kenneth G Kowalski, Xiao Tong, Samantha Budd Haeberlein, Rajasimhan Rajagovindan, Ivan Nestorov
Characterization of exposure-Clinical Dementia Rating-Sum of Boxes relationship in subjects with early Alzheimer's disease from the aducanumab Phase 3 trials. Journal of pharmacokinetics and pharmacodynamics 50 (1) (2023)
Lin Lin, Fei Hua, Cristian Salinas, Carissa Young, Thierry Bussiere, Joshua F Apgar, John M Burke, Kumar Kandadi Muralidharan, Rajasimhan Rajagovindan, Ivan Nestorov
Quantitative systems pharmacology model for Alzheimer's disease to predict the effect of aducanumab on brain amyloid. CPT: pharmacometrics & systems pharmacology 11 (3) (2022)